Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT01700322
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose basic science
- Phase
- Phase 4
- Enrolled
- 126 participants
- Registry
-
NCT01700322
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01700322. Randomized; single masking; primary purpose basic science. Start 2012-08 (registry gives no type); primary completion 2016-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
- Acronym
- EST
- Condition
- Coronary Artery Disease
- Intervention (Procedure)
- Coronary stenting
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- Johannes Gutenberg University Mainz
Record details
- Record id
cardio:ct-nct01700322- Content hash
8d9b2e3d05ad701d838a7f1197b9100379b216ec8ee4814310828c84c2cc9a30